Taking a deeper dive: Novel gene therapy approaches to treat ocular disease

Investigators find that nanoparticles deliver gene therapy successfully in mice, rats

Robotics allow surgeons to perform the seemingly impossible

Automated assistance controls tremor, reduces fatigue, and helps avoid inadvertent injury

Bausch Health to acquire option to purchase ophthalmology assets of Allegro

Agreement would include global rights for investigational treatment, risuteganib, expected to help reverse vision loss due to dry AMD

Harnessing regeneration of retinal tissues: An option almost within reach

September 17, 2020

This ability would unlock possibilities for repairing tissue damaged by disease

Persistent retinal detachment associated with retinoblastoma

September 16, 2020

Watchful waiting may prove to be beneficial in complicated cases

Targeting AMD patient treatment burden

September 15, 2020

Intravitreal gene therapy continues to be well tolerated; shows robust efficacy

Novartis: Positive DME data for brolucizumab in KITE trial

September 14, 2020

Novartis has announced positive topline results from the phase 3 KITE study of brolucizumab 6 mg versus aflibercept for patients with diabetic macular edema.

OCTA: Why the jury may still be out

September 11, 2020

Though OCTA has become indispensable for managing macular degeneration and diabetic retinopathy, Robert L. Stamper, MD, explains why the technology must become more sophisticated and evolved before it reaches its full potential for glaucoma specialists.

Regenxbio: Dosing of first patient in Phase 2 AAVIATE trial for wet AMD

September 09, 2020

Interim data update from first cohort using suprachoroidal delivery of RGX-314 expected by end of 2020

FA implant outperforms anti-VEGF in DR patients lost-to-follow-up

September 08, 2020

Results could provide a new preferred treatment paradigm for this population

Deep learning algorithm proving accurate for AMD classification

September 01, 2020

Results of a prospective trial show the tool is ready for clinical use and potential deployment for remote telemedical use.

Managing the challenge of cataract surgery in eyes with diabetic macular edema

September 01, 2020

Researchers advocate for intraoperative intravitreal steroid during cataract surgery in patients with DME.

Contrast sensitivity shows potential for measuring visual function loss in early AMD

September 01, 2020

A study suggests this user-friendly platform may be useful as a supplemental visual function measure in patients with AMD.

Identifying biomarkers to predict diabetic retinopathy progression

September 01, 2020

Study explores correlations between functional and structural tests

The future of ophthalmology: Part III

August 29, 2020

Susan Coultas, PhD, and Preeya Gupta, MD, share their hopes for continued innovation in the ophthalmic space — including dry eye and retina — as well as the importance of the clinical research process.

Putting in practice retina innovations amid a pandemic

August 28, 2020

S.K. Steven Houston III, MD, shares how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current COVID-19 environment.

Improving visual outcomes after 360° relaxing retinectomy

August 27, 2020

The application of sub-silicone oil TA crystals over relaxing retinectomy sites is a viable option in patients with complex RD with extreme PVR.

What photobiomodulation may mean for patients with dry AMD

August 25, 2020

Find out how the LIGHTSITE I results may pave the way for a new treatment approach.